Hai education bus

HAI Watch News

HAI Watch health portal

Not on my watch is a disease awareness effort from Kimberly-Clark to educate both the healthcare community and general public on the risks of Health-Associated infection (HAI). The program includes a web portal, a tour bus which features a mini-classroom to give accredited CHE/CME formations regarding HAI on-site and a PR microsite supplying information to media outlets about the program.

The HAI Watch health portal is a resource to help keep health organizations aware of the importance of health-associated infection prevention. The site sections include:

• HAI issues (Ventilator-Associated Pneumonia (VAP) / Surgical Site Infections (SSI) / Cross Contamination)
• Tools (which is extensive with lists of guidelines and links to useful information)
• Clinical Education (which offers accredited CHE programs)
• News and events
• AI champions (with feature stories and case studies)
• Partners and organizations

Plus New HAI awareness tools are added on an ongoing basis.

haiwatchnews.com is a PR page set by Abraham & Harrison to inform medias about the problem and where to find multi-media materials to spread the word.

Also part of the program are two YouTube videos, the first one is about the program itself.

And the second YouTube video is about proper hand-washing to prevent infection and it’s produced by the CDC.

Agency: Abraham & Harrison

Brand name: HAI – Not on my watch
Generic name/category: public service and awareness
Company: Kimberly-Clark
Country/Market: USA, North America
Indication(s)/use: Health-Associated Infections
Target: Consumers (DTC) / Healthcare Professionals (HCP)
Tagline: Not on my watch
Medium: Internet
Size/duration: Web site / Portal / Social Media
Publication/Aired: 2009
Source: haiwatchnews.com/

More Social Media on AdPharm.net

Some see inhibitors as a lifetime of tests, bleeds, and complications.
Novo Nordisk helps them see a lifetime of possibilities.

Click on image to view ad details and full-size version on AdPharm.

To see all of this brand’s ads on AdPharm, click here

This GSK site in the UK is primarily an informal site on GSK drugs, what they do, and with quick access to the treatments’ patient information. There’s also a section to report adverse events.

Description of the site from GSK: This site is intended for the UK public only. It is designed to provide easy access to information about GSK UK products and their disease areas. The aim is to provide straightforward information on our products. Links are provided to the relevant support web sites to aid you in your search for information.

Public site
Entry page > Public home > Public sample drug information page > Public Adverse events reporting page

Healthcare professional site
Entry page > HCP home > HCP sample drug information page > HCP Adverse events reporting page

Click here to visit the site

To see all of the ads from this campaign, click here

PNH is destructive, progressive, and life threatening.
What will you do?

Soliris: The power to protect.
The first humanized monoclonal antibody (MAb) to reduce hemolysis and its harmful effects in all PNH patients.

Brand name: Soliris

Generic name/category: Eculizumab, Monoclonal antibodies, Immunosuppressants
Company: Alexion Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: Hemolysis reduction in Paroxysmal nocturnal haemoglobinuria (PNH)
Target: Healthcare Professionals (HCP)
Tagline: Soliris. The power to protect
Medium: Print ad
Size/duration: double-page spread
Publication/Aired: Blood – September 24, 2009

Click on thumbnail to view the full-size ad on AdPharm

She couldn’t imagine her future without depression. But we can.

Generic name/category: Corporate communications
Company: Wyeth Neuroscience
Country/Market: USA, North America
Indication(s)/use: Neurodegeneration, Pain, Schizophrenia and bipolar disorder and Depression and Anxiety
Target: Healthcare Professionals (HCP)
Tagline: Research. Education. Innovation
Medium: Print ad
Size/duration: single-page
Publication/Aired: Managed Care – February 2008

To see all of this brand’s ads on AdPharm, click here

Click on thumbnail to view the full-size ad on AdPharm

Constipation.
When is this common complaint a chronic condition?

Approximately 1 in 4 people are affected.
1 in 5 people suffer for years.

Chronic constipation needs chronic therapy.
To learn more, please visit: www.constipationlearningchannel.com

Brand name: The constipation learning channel
Generic name/category: disease awareness
Company: Sucampo Pharmaceuticals, Takeda and Tap Pharmaceuticals
Country/Market: USA, North America
Indication(s)/use: constipation
Target: Healthcare Professionals (HCP)
Tagline: Chronic constipation needs chronic therapy.
Medium: Print ad
Size/duration: single-page
Publication/Aired: Drug Topic – November 2008